Your browser doesn't support javascript.
loading
The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy.
Ball, Brian J; Hsu, Meier; Devlin, Sean M; Arcila, Maria; Roshal, Mikhail; Zhang, Yanming; Famulare, Chris A; Goldberg, Aaron D; Cai, Sheng F; Dunbar, Andrew; Epstein-Peterson, Zachary; Menghrajani, Kamal N; Glass, Jacob L; Taylor, Justin; Viny, Aaron D; Giralt, Sergio S; Gyurkocza, Boglarka; Shaffer, Brian C; Tamari, Roni; Levine, Ross L; Tallman, Martin S; Stein, Eytan M.
Afiliação
  • Ball BJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.
  • Hsu M; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Devlin SM; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Arcila M; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Roshal M; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zhang Y; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Famulare CA; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Goldberg AD; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cai SF; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Dunbar A; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Epstein-Peterson Z; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Menghrajani KN; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Glass JL; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Taylor J; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Viny AD; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Giralt SS; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gyurkocza B; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Shaffer BC; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tamari R; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Levine RL; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tallman MS; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Stein EM; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Am J Hematol ; 96(5): E171-E175, 2021 05 01.
Article em En | MEDLINE | ID: mdl-33650111
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Genes ras / Quimioterapia de Indução / Mutação com Ganho de Função / Mutação Tipo de estudo: Prognostic_studies Limite: Humans / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Genes ras / Quimioterapia de Indução / Mutação com Ganho de Função / Mutação Tipo de estudo: Prognostic_studies Limite: Humans / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article